BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gross-Cohen M, Yanku Y, Kessler O, Barash U, Boyango I, Cid-Arregui A, Neufeld G, Ilan N, Vlodavsky I. Heparanase 2 (Hpa2) attenuates tumor growth by inducing Sox2 expression. Matrix Biol 2021;99:58-71. [PMID: 34004353 DOI: 10.1016/j.matbio.2021.05.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Beaman GM, Lopes FM, Hofmann A, Roesch W, Promm M, Bijlsma EK, Patel C, Akinci A, Burgu B, Knijnenburg J, Ho G, Aufschlaeger C, Dathe S, Voelckel MA, Cohen M, Yue WW, Stuart HM, Mckenzie EA, Elvin M, Roberts NA, Woolf AS, Newman WG. Expanding the HPSE2 Genotypic Spectrum in Urofacial Syndrome, A Disease Featuring a Peripheral Neuropathy of the Urinary Bladder. Front Genet 2022;13:896125. [DOI: 10.3389/fgene.2022.896125] [Reference Citation Analysis]
2 Knani I, Singh P, Gross-Cohen M, Aviram S, Ilan N, Sanderson RD, Aronheim A, Vlodavsky I. Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3. Matrix Biol 2021:S0945-053X(21)00105-0. [PMID: 34808335 DOI: 10.1016/j.matbio.2021.11.001] [Reference Citation Analysis]
3 Dehshahri A, Biagioni A, Bayat H, Lee EHC, Hashemabadi M, Fekri HS, Zarrabi A, Mohammadinejad R, Kumar AP. Editing SOX Genes by CRISPR-Cas: Current Insights and Future Perspectives. Int J Mol Sci 2021;22:11321. [PMID: 34768751 DOI: 10.3390/ijms222111321] [Reference Citation Analysis]
4 Karamanos NK, Piperigkou Z, Passi A, Götte M, Rousselle P, Vlodavsky I. Extracellular matrix-based cancer targeting. Trends Mol Med 2021:S1471-4914(21)00190-8. [PMID: 34389240 DOI: 10.1016/j.molmed.2021.07.009] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
5 Liu J, Knani I, Gross-Cohen M, Hu J, Wang S, Tang L, Ilan N, Yang S, Vlodavsky I. Role of heparanase 2 (Hpa2) in gastric cancer. Neoplasia 2021;23:966-78. [PMID: 34343822 DOI: 10.1016/j.neo.2021.07.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]